Multidrug nanomedicine

Nat Nanotechnol. 2023 Feb;18(2):104-106. doi: 10.1038/s41565-022-01265-3.

Authors

Alexandros Marios Sofias¹, Twan Lammers²

Affiliations

¹ Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, University Hospital RWTH Aachen, Aachen, Germany. [email protected].
² Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, University Hospital RWTH Aachen, Aachen, Germany. [email protected].

PMID: 36805554
DOI: 10.1038/s41565-022-01265-3

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antineoplastic Agents* / pharmacology
Drug Delivery Systems
Drug Resistance, Neoplasm
Humans
Nanomedicine
Neoplasms* / drug therapy

Substances

Antineoplastic Agents